LIGAND PHARMACEUTICALS INCORPORATED

(NASDAQ:LGND)

2.04

+0.03 (1.49%)

Dec 04 - Close

Open
1.98
High
2.08
Low
1.93
Vol.
257.78K
Mkt Cap
190.83M
52Wk High
5.82
52Wk Low
1.10
Avg. Vol.
667.20K
P/E (Trailing)
-9.71
Beta
1.29
Short %
7.10%
Div. Yield
—

After-Hours 2.06 +0.02 (0.98%) Thu, 4 Dec 2008 7:40 PM

Company Profile

LIGAND PHARMACEUTICALS INCORPORATED

10275 Science Center Drive

San Diego, CA 92121-1117

United States - Map

Phone: (858) 550-7500

Fax: (858) 550-1826

Website: www.ligand.com

State of incorporation: Delaware

CEO: John L. Higgins

Employees: 59

Sector: Healthcare

Industry Group: Drugs

Industry: Drug Manufacturers - Other

Dev drugs that regulate hormone-activated receptor

An early-stage biotech company that focuses on discovering and developing new drugs that address critical unmet medical needs in the areas of thrombocytopenia, anemia, cancer, hormone-related diseases, osteoporosis and inflammatory diseases

Recent news for LGND

Recent opinions on LGND

No recent Opinions for LGND

Top members owning LGND

Members owning LGND also own

ANDE (100.00%), BDAY (100.00%), EBAY (100.00%), PACT (100.00%), COP (100.00%)

Member sentiment: Neutral